Sheng H, Lu Y, Chen H
Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, China.
Transplant Proc. 2008 Dec;40(10):3590-3. doi: 10.1016/j.transproceed.2008.06.081.
The purpose of this study was to investigate ocular complications among a group of patients on long-term, high-dose immunosuppression and corticosteroids for the maintenance of orthotopic heart transplants. Additionally, we provided information pertinent for the early diagnosis and treatment of eye diseases. In this study, we retrospectively assessed the clinical data of 138 patients with orthotopic heart transplantations from May 2000 to October 2005, including assessment of ophthalmic symptoms and signs, as well as the general condition, treatment, and prognosis. Of 138 transplant recipients examined (276 eyes), 47 eyes (17.0%) showed ocular surface diseases. Sixty-four (23.2%) had a posterior subcapsular cataract, and 16 (5.8%) corticosteroid glaucoma. Fifteen (5.6%) had ocular fundus diseases. Various ocular complications related to immunosuppression and corticosteroids appear among heart transplant patients. Cardiac surgeons and ophthalmologists must closely evaluate ocular symptoms in the posttransplantation period.
本研究的目的是调查一组接受长期、大剂量免疫抑制和皮质类固醇治疗以维持原位心脏移植的患者的眼部并发症。此外,我们提供了与眼病早期诊断和治疗相关的信息。在本研究中,我们回顾性评估了2000年5月至2005年10月期间138例原位心脏移植患者的临床资料,包括眼科症状和体征评估,以及一般状况、治疗和预后。在接受检查的138例移植受者(276只眼)中,47只眼(17.0%)出现眼表疾病。64只眼(23.2%)患有后囊下白内障,16只眼(5.8%)患有皮质类固醇性青光眼。15只眼(5.6%)患有眼底疾病。心脏移植患者中出现了各种与免疫抑制和皮质类固醇相关的眼部并发症。心脏外科医生和眼科医生必须在移植后密切评估眼部症状。